Peter B. Schiff

ORCID: 0000-0003-1982-0933

Also affiliated with New York University

Physics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.”.

Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4504

N/A

0DataRank · unranked

42 citations

Matthew I. Milowsky, Peter H. O’Donnell, Ajjai Alva, Marisa Kollmeier, Tracy L. Rose +15 more

Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109571

N/A

0DataRank · unranked

14 citations

Poonam Yadav, Aaron Andersen, Zhe Jay Chen, Long Huang, Márk Langer +8 more